1. Home
  2. SRRK vs CACC Comparison

SRRK vs CACC Comparison

Compare SRRK & CACC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Scholar Rock Holding Corporation

SRRK

Scholar Rock Holding Corporation

N/A

Current Price

$56.23

Market Cap

6.8B

Sector

Health Care

ML Signal

N/A

Logo Credit Acceptance Corporation

CACC

Credit Acceptance Corporation

N/A

Current Price

$599.58

Market Cap

6.0B

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
SRRK
CACC
Founded
2012
1972
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Finance: Consumer Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
6.8B
6.0B
IPO Year
2018
1996

Fundamental Metrics

Financial Performance
Metric
SRRK
CACC
Price
$56.23
$599.58
Analyst Decision
Strong Buy
Hold
Analyst Count
13
2
Target Price
$56.17
$505.00
AVG Volume (30 Days)
981.1K
103.3K
Earning Date
05-07-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
83.00
EPS
N/A
25.04
Revenue
N/A
$2,317,200,000.00
Revenue This Year
N/A
$91.73
Revenue Next Year
$534.24
$3.58
P/E Ratio
N/A
$23.40
Revenue Growth
N/A
7.16
52 Week Low
$27.07
$401.90
52 Week High
$58.49
$668.86

Technical Indicators

Market Signals
Indicator
SRRK
CACC
Relative Strength Index (RSI) 62.50 56.55
Support Level $45.81 $535.20
Resistance Level $58.49 $621.52
Average True Range (ATR) 2.38 18.47
MACD 0.63 2.43
Stochastic Oscillator 93.21 64.31

Price Performance

Historical Comparison
SRRK
CACC

About SRRK Scholar Rock Holding Corporation

Scholar Rock Holding Corp is a biopharmaceutical company focused on improving the lives of children and adults with Spinal Muscular Atrophy and other rare, severe, and debilitating neuromuscular diseases. Its pipeline candidates include apitegromab and a subcutaneous formulation of apitegromab. The clinical-stage pipeline also includes SRK-439, an investigational subcutaneously administered fully human anti-pro/latent myostatin antibody with high inhibitory potency and selectivity toward myostatin, being developed for the treatment of rare neuromuscular diseases. The company also maintains early-stage programs focused on therapies for rare, severe, and debilitating neuromuscular diseases.

About CACC Credit Acceptance Corporation

Credit Acceptance Corp is a consumer finance company that specializes in automobile loans. These loans are offered through a U.S. nationwide network of automobile dealers that benefit from sales of vehicles to consumers who could otherwise not obtain financing. The company also benefits from repeat and referral sales, and from sales to customers responding to advertisements for financing, but qualify for traditional financing. The company derives its revenue from finance charges, premiums earned on the reinsurance of vehicle service contracts, and other fees. Of these, financing charges, including servicing fees, are by far a source of revenue.

Share on Social Networks: